Anti-fibrotic mechanisms of angiotensin AT2 -receptor stimulation

Colin Sumners, A Augusto Peluso, Andreas Houe Hausgaard, Jesper Bork Bertelsen, U Muscha Steckelings

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

98 Downloads (Pure)


The angiotensin AT2 -receptor is a main receptor of the protective arm of the renin-angiotensin-system. Understanding of this unconventional G-protein coupled receptor has significantly advanced during the past decade, largely because of the availability of a selective non-peptide AT2 -receptor agonist, which allowed the conduct of a multitude of studies in animal disease models. This article reviews such preclinical studies that in their entirety provide strong evidence for an anti-fibrotic effect mediated by activation of the AT2 -receptor. Prevention of the development of fibrosis by AT2 -receptor stimulation has been demonstrated in lung, heart, blood vessels, kidney, pancreas and skin. In lung, AT2 -receptor stimulation was even able to reverse existing fibrosis. The article further discusses intracellular signalling mechanisms mediating the AT2 -receptor coupled anti-fibrotic effect, including activation of phosphatases and subsequent interference with pro-fibrotic signalling pathways, induction of matrix-metalloproteinases, and hetero-dimerisation with the AT1 -receptor, the TGF-βRII-receptor or the RXFP1-receptor for relaxin. Knowledge of the anti-fibrotic effects of the AT2 -receptor is of particular relevance, because drugs targeting this receptor have entered clinical development for indications involving fibrotic diseases. This article is protected by copyright. All rights reserved.

TidsskriftActa Physiologica
Udgave nummer1
Antal sider16
StatusUdgivet - sep. 2019


Dyk ned i forskningsemnerne om 'Anti-fibrotic mechanisms of angiotensin AT2 -receptor stimulation'. Sammen danner de et unikt fingeraftryk.